chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Myalgia, Pain, Tremor, Vaccination site erythema
Clinical narrative: Body aches; Shaking; Muscle soreness; Redness at injection site; Vomiting; Dose 1 on 31May2021 and Dose 2 on 06Jun2021; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Jun2021 at 11:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and ethinylestradiol; norgestimate (SPRINTEC) both taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31May2021 at 11:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation and took rizatriptan (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and experienced the drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jun2021 at 22:00, the patient experienced body aches, shaking, muscle soreness, redness at injection site and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was not received for the reported events. The clinical outcomes of the events body aches, shaking, muscle soreness, redness at injection site and vomiting were resolving, at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Body aches; Shaking; Muscle soreness; Redness at injection site; Vomiting; Dose 1 on 31May2021 and Dose 2 on 06Jun2021; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Jun2021 at 11:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and ethinylestradiol; norgestimate (SPRINTEC) both taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31May2021 at 11:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation and took rizatriptan (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and experienced the drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jun2021 at 22:00, the patient experienced body aches, shaking, muscle soreness, redness at injection site and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was not received for the reported events. The clinical outcomes of the events body aches, shaking, muscle soreness, redness at injection site and vomiting were resolving, at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blister, Dizziness, Fatigue, Headache, Muscular weakness
Clinical narrative: Body ache; Strong headache; Weak arm; Dizziness; Feeling tired; Rashes on his legs; Blisters at the bottom of his feet; Always sleepy; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (reported for himself). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 11Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced body ache, strong headache, weak arm, dizziness, feeling tired, rashes on his legs, blisters at the bottom of his feet and always sleepy. The clinical course was as follows: The reporter would like to know if that is normal and if he will die soon or if he will live long. Reporter also wants to know if his wife and kids will be infected with the side effects that he is experiencing and if there is a compensation program. Dose 2 was scheduled on 06May2021. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash, Somnolence
Clinical narrative: Body ache; Strong headache; Weak arm; Dizziness; Feeling tired; Rashes on his legs; Blisters at the bottom of his feet; Always sleepy; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (reported for himself). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 11Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced body ache, strong headache, weak arm, dizziness, feeling tired, rashes on his legs, blisters at the bottom of his feet and always sleepy. The clinical course was as follows: The reporter would like to know if that is normal and if he will die soon or if he will live long. Reporter also wants to know if his wife and kids will be infected with the side effects that he is experiencing and if there is a compensation program. Dose 2 was scheduled on 06May2021. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscular weakness, Paraesthesia
Clinical narrative: Left arm/ right arm/ both legs felt numbness; Left arm/ right arm/ both legs/ hands and feet felt tingling; Left arm/ right arm/ both legs felt muscle weakness; continue to have numbness andtingling in my arms and legs, handsand feet.; continue to have numbness andtingling in my arms and legs, handsand feet.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the left arm on 11Jun2021 at 16:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies to food, medication or other product. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown start date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 21May2021 at 16:00(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Jun2021 at 16:15, within 10 minutes of receiving the second dose of the vaccine, patient left arm felt numbness and tingling. Within an hour after the vaccine, both of her legs and right arm also felt numbness, tingling, and muscle weakness. It was now 12 days post vaccine and she continued to have numbness and tingling in her arms and legs, hands and feet. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with prednisone (MANUFACTURER UNKNOWN). The clinical outcome of the events left arm, both legs, right arm, hands, feet numbness, tingling, muscle weakness were not recovered at the time of this report.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Mental disorder
Clinical narrative: Severe altered mental in a healthy 16 year old; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Jun2021 at 09:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and was reported to be healthy. The patient did not receive any medication within two weeks of vaccination. The patient previously took amoxicillin and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 26May2021 at 09:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Jun2021 at 13:00, the patient experienced severe altered mental for a healthy 16-year-old. The event resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event severe altered mental was not resolved at the time of report.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles diagnosis today 6/23/2021; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18Mar2021 at 12:00 (at the age of 47-year-old) as a single dose for COVID-19 immunization. The patient had no relevant medical history. Concomitant medications included finasteride (FINESTERIDE) and rosuvastatin calcium (ROTUVASTATIN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Jun2021 at 12:00, the patient experienced shingles. Shingles diagnosis the day of reporting on 23Jun2021. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles which included shingles treatment. The clinical outcome of the event shingles was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in the arm and hand (left arm and hand); This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW196) via an unspecified route of administration in the left arm on 22Jun2021 at 11:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications of the patient were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 26May2021 at 09:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Jun2021 at 17:00, next day of vaccination, the patient experienced numbness in the arm and hand where the vaccine was received (left arm and hand). The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event numbness in the arm and hand (left arm and hand) was recovering at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthropathy, Visual impairment
Clinical narrative: Issues with my eyesight; My left knee now has issues; I am just worried; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 for COVID-19 immunization. On an unspecified date, patient experienced issues with my eyesight, my left knee now has issues, I am just worried. Patient wanted to know what to do or should I expect in future. The clinical outcome of events was unknown.  Information about batch/lot number has been requested.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue
Clinical narrative: My reaction was within a couple of hours of getting 2nd vaccine, I experienced extreme fatigue and could not stay away. I proceeded to sleep for the next 24 hours. I started experiencing Shortness of breath; My reaction was within a couple of hours of getting 2nd vaccine, I experienced extreme fatigue and could not stay away. I proceeded to sleep for the next 24 hours. I started experiencing Shortness of breath; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 46-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 16Mar2021 at 11:00 as DOSE 2 (age at vaccination: 46-years-old), SINGLE for covid-19 immunisation. Medical history included food allergy (Shellfish). The patient's concomitant medications were not reported. The patient received dose 1 of bnt162b2 on 23FEB2021 for COVID-19 Immunisation (administration time: 10:00 AM, vaccine location: Left arm). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced my reaction was within a couple of hours of getting 2nd vaccine, I experienced extreme fatigue and could not stay away. I proceeded to sleep for the next 24 hours. I started experiencing shortness of breath on 23Mar2021. The patient did not receive any treatment for the events. Adverse events resulted in: Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 11Jun2021, sars-cov-2 test: negative on 11Jun2021. Outcome of the events My reaction was within a couple of hours of getting 2nd vaccine, I experienced extreme fatigue and could not stay away. I proceeded to sleep for the next 24 hours. I started experiencing Shortness of breath (Fatigue extreme) was Not recovered (the extreme fatigue continues to be a daily issue and only appears to be worse), My reaction was within a couple of hours of getting 2nd vaccine, I experienced extreme fatigue and could not stay away. I proceeded to sleep for the next 24 hours. I started experiencing Shortness of breath (Shortness of breath) was Recovering (While the shortness of breath seems to be dissipating slowly over the last couple of weeks).
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, Sneezing
Clinical narrative: caught a cold: sniffles, sneezing, sore throat, a lot of congestion; caught a cold: sniffles, sneezing, sore throat, a lot of congestion; caught a cold: sniffles, sneezing, sore throat, a lot of congestion; caught a cold: sniffles, sneezing, sore throat, a lot of congestion; caught a cold: sniffles, sneezing, sore throat, a lot of congestion; This is a spontaneous report from a contactable consumer or other non-health professional (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration on 04Jun2021, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced caught a cold: sniffles, sneezing, sore throat, a lot of congestion. Caller wants to know if she can take the second dose of the Pfizer Covid vaccine as scheduled or should she wait until after the cold resolves. Caller states she does not think it is from the vaccine tho, her brother was sneezing or whatever and thought it was allergies and then her boyfriend, daughter, son, sister, brother, mother, everyone got it. Caller was speaking fast and clarified that everyone got a cold. It started off as a sore throat then it was sneezing and that was it, no fever, but a lot of congestion. The outcome for all the events was unknown.  Information on the lot/batch number has been requested.  Follow-up #01 (25Jun2021): This is a Follow-up Spontaneous report from a contactable consumer female(patient) reported that: Updated in narrative.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Heart rate, Heart rate increased, SARS-CoV-2 test
Clinical narrative: Elevated heart rate.  My normal resting heart rate is mid 60s.  After the 2nd shot, my resting heart rate is consistently at 80 or higher.; This is a spontaneous report from a contactable consumer or other non hcp.  A 49-years-old male patient received bnt162b2 (BNT162B2, solution for injection), dose 2 intramuscular, administered in Arm Right on 13May2021 12:00 (Lot Number: EW0179) as DOSE 2, SINGLE for covid-19 immunisation (at the age of 49 years). The patient medical history was not reported. There were no concomitant medications. The patient received historic vaccine bnt162b2 (BNT162B2, solution for injection, Lot number: EW0172), dose1 Left arm via Intramuscular route on 22 Apr 2021 at12:00 PM and experienced Flu symptoms.The patient did not take any vaccine in four weeks nor other medications in two weeks. There were no known allergies. The patient experienced elevated heart rate in Jun 2021.Patients normal resting heart rate is mid-60s, after the 2nd shot, his resting heart rate is consistently at 80 or higher. The patient was not tested covid post vaccination. He had covid prior vaccination. There was no treatment received for event. The patient underwent lab tests and procedures which included electrocardiogram: appears normal, heart rate:mid 60's, sars-cov-2 test:positive on 10Nov2020 , sars-cov-2 test: negative.on 20Nov2020, sars-cov-2 test: negative on 23Nov2020, sars-cov-2 test: negative on 03Dec2020. The outcome of event was recovering.  Follow-up attempts are completed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Back pain, Burning sensation, Pain in extremity, Pyrexia
Clinical narrative: 1. Low grade fever more than 99.2 after 5hours 2. Both  Knee pain and burning whole night  3. Lower back pain right hip and right thigh
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Fall, Headache, Loss of consciousness
Clinical narrative: Got the second dose of Pfizer on 8/27/21 at 2pm and today, 8/28/21 at 12pm, I briefly blacked out and fell/came to while falling and had a cold sweat for 10 minutes afterwards.  Have had mild headache/aches/chills/fever all day otherwise.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Got the second dose of Pfizer on 8/27/21 at 2pm and today, 8/28/21 at 12pm, I briefly blacked out and fell/came to while falling and had a cold sweat for 10 minutes afterwards.  Have had mild headache/aches/chills/fever all day otherwise.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Hypertension
Clinical narrative: Patient complained of not being able to breathe ten minutes after getting the shot. Stated " I felt anxious before the shot. Her vital signs were checked  at1:30 pm, blood pressure 149/93, heart rate 79, respiration 18, pulse ox 99% on room air. She denied dizziness, tachycardia or tightness in the chest.  Cold compress was applied to the back of her neck , and she drank water offered to her. BP at 2pm  152/ 107, HR 70. No ditress noted, patient refusedcto have 911 called for more evaluation due to high blood pressure.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Pain in extremity
Clinical narrative: Body aches not associated with a sore arm. Resembles flu-like body aches
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Feeling hot, Hyperhidrosis, Hypoaesthesia
Clinical narrative: -> tighting chest & sweating -> Not control over body -> Finger & thumb & hand numbness -> extremely warm body inside -> Breathing problem
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Biopsy breast normal, Cell marker, Chills, Cough
Clinical narrative: 1) After at 6-8 hours (for both 1st & 2nd dose) fever, chills, headache, cough, extreme weakness & dizziness 2) on routine memogram (3/11/21) abnormality found. Detailed memogram (3/23/21) abnormal. Biopsy (3/25/21) normal metal chip insertion left breast 2 weeks of extreme mental stress, left full time job which was just joined in different city.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Emotional distress, Headache, Impaired work ability, Mammogram abnormal
Clinical narrative: 1) After at 6-8 hours (for both 1st & 2nd dose) fever, chills, headache, cough, extreme weakness & dizziness 2) on routine memogram (3/11/21) abnormality found. Detailed memogram (3/23/21) abnormal. Biopsy (3/25/21) normal metal chip insertion left breast 2 weeks of extreme mental stress, left full time job which was just joined in different city.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: 1) After at 6-8 hours (for both 1st & 2nd dose) fever, chills, headache, cough, extreme weakness & dizziness 2) on routine memogram (3/11/21) abnormality found. Detailed memogram (3/23/21) abnormal. Biopsy (3/25/21) normal metal chip insertion left breast 2 weeks of extreme mental stress, left full time job which was just joined in different city.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Nausea
Clinical narrative: Pt felt lightheaded and nauseous. Face slightly reddish. No signs of anaphylaxis. Pt did drink water, Pt laid down on 2 chairs. Mother Present.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Peripheral swelling, Rash, Urticaria
Clinical narrative: Patient developed full body welt like rash arm/hands swollen, stated difficulty breathing on 8/24 but resolved, recommended to go to urgent care.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Barium swallow normal, Cardiac monitoring abnormal, Cardiac stress test normal, Chest discomfort, Chest pain
Clinical narrative: Received #2 COVID vaccine 2/23/21. While taking bedtime meds pm 2/25/21, sudden onset very severe chest pain/pressure midsternum as if pill swallowed "sideways". No changes in BP, pulse or ECG trcing on fitness watch. Felt pain due to GI issue. Pain (less severe) con't through weekend, also noticed onset of palpitations. Saw primary dr 3/2/21. She ordered labs, barium swallow, ziopatch x 7 days, GI consult, did ECG in office. Only ziopatch showed results with runs of SVT, & PVC's. My primary Dr ordered a cardiac consult. Cardiologist ordered stress test (essentially normal), echocardiogram. Cardiologist said echocardiogram showed some pericardial effusion - didn't know why I woulld have that. I will have a repeat echocaRdiogram on 8/31/21. Have Not yet discussed possible vacciNe event with cardiologist. To see cardiologist 9/10/21.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Gastrointestinal disorder, Pain, Palpitations, Pericardial effusion
Clinical narrative: Received #2 COVID vaccine 2/23/21. While taking bedtime meds pm 2/25/21, sudden onset very severe chest pain/pressure midsternum as if pill swallowed "sideways". No changes in BP, pulse or ECG trcing on fitness watch. Felt pain due to GI issue. Pain (less severe) con't through weekend, also noticed onset of palpitations. Saw primary dr 3/2/21. She ordered labs, barium swallow, ziopatch x 7 days, GI consult, did ECG in office. Only ziopatch showed results with runs of SVT, & PVC's. My primary Dr ordered a cardiac consult. Cardiologist ordered stress test (essentially normal), echocardiogram. Cardiologist said echocardiogram showed some pericardial effusion - didn't know why I woulld have that. I will have a repeat echocaRdiogram on 8/31/21. Have Not yet discussed possible vacciNe event with cardiologist. To see cardiologist 9/10/21.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Supraventricular tachycardia, Ventricular extrasystoles
Clinical narrative: Received #2 COVID vaccine 2/23/21. While taking bedtime meds pm 2/25/21, sudden onset very severe chest pain/pressure midsternum as if pill swallowed "sideways". No changes in BP, pulse or ECG trcing on fitness watch. Felt pain due to GI issue. Pain (less severe) con't through weekend, also noticed onset of palpitations. Saw primary dr 3/2/21. She ordered labs, barium swallow, ziopatch x 7 days, GI consult, did ECG in office. Only ziopatch showed results with runs of SVT, & PVC's. My primary Dr ordered a cardiac consult. Cardiologist ordered stress test (essentially normal), echocardiogram. Cardiologist said echocardiogram showed some pericardial effusion - didn't know why I woulld have that. I will have a repeat echocaRdiogram on 8/31/21. Have Not yet discussed possible vacciNe event with cardiologist. To see cardiologist 9/10/21.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Rash, Urticaria
Clinical narrative: Patient developed welt type rash all over body and felt he had hard time breathing. Reaction started hours after vaccine. Came to pharmacy 6 days later. I spoke with his caregiver. Patient reported breathing ok now + rash slowly resolving.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Nausea, Vomiting
Clinical narrative: Patient came to pharmacy with his son when had a drug RXn and also said he experienced nausea, vomiting, severe joint pain, extreme fatigue after his vaccination lated couple of days
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Myoclonus, Postictal state, Unresponsive to stimuli
Clinical narrative: Vaccine was administered at 12:12pm and patient was sitting in waiting room when she fell on the floor, entered myoclonus, and become unresponsive, I offered to call 911 but the patient's friend explained she was a nurse and that we do not need to call since this has happened before. The patient remained on the floor in a postictal state for about 15 minutes before leaving with her friend feeling normal.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Depersonalisation/derealisation disorder, Dry throat, Pain
Clinical narrative: he slept 12-14 hours; pain; soreness in left shoulder and arm to wrist in the injection arm; soreness in arm in the injection arm; Fever; Dry throat; Weakness; did not feel himself; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on an unspecified date in 2021 (Batch/Lot number and expiration date not reported) as dose 1, single and via an unspecified route of administration, administered in the left arm on an unspecified date in 2021 (Batch/Lot number and expiration date not reported) as dose 2, single; both for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced he slept 12-14 hours, pain, soreness in left shoulder and arm to wrist in the injection arm, had fever, dry throat, weakness and did not feel himself on an unspecified date in 2021. It was reported that the patient has similar symptoms after the first shot but mild. The outcome of the events was recovered on an unspecified date in 2021 (reported as side effects were gone now). The caller was querying when does this vaccine start protecting after the second dose, if 7 days or 14 days.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Somnolence
Clinical narrative: he slept 12-14 hours; pain; soreness in left shoulder and arm to wrist in the injection arm; soreness in arm in the injection arm; Fever; Dry throat; Weakness; did not feel himself; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on an unspecified date in 2021 (Batch/Lot number and expiration date not reported) as dose 1, single and via an unspecified route of administration, administered in the left arm on an unspecified date in 2021 (Batch/Lot number and expiration date not reported) as dose 2, single; both for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced he slept 12-14 hours, pain, soreness in left shoulder and arm to wrist in the injection arm, had fever, dry throat, weakness and did not feel himself on an unspecified date in 2021. It was reported that the patient has similar symptoms after the first shot but mild. The outcome of the events was recovered on an unspecified date in 2021 (reported as side effects were gone now). The caller was querying when does this vaccine start protecting after the second dose, if 7 days or 14 days.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hypoaesthesia, Lip swelling, Paraesthesia, Pharyngeal swelling
Clinical narrative: Immediate anaphylaxis.  Administered Epinephrine and took ambulance to hospital.  Have since had a lasting histamine intolerance and multiple hospitalizations with no history before shot.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Histamine intolerance, Immediate post-injection reaction
Clinical narrative: Immediate anaphylaxis.  Administered Epinephrine and took ambulance to hospital.  Have since had a lasting histamine intolerance and multiple hospitalizations with no history before shot.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Injection site swelling
Clinical narrative: 3 days post vaccine, lime size lump under left arm and swollen glands under arm that stings/burns.; Then lumps appeared in elbow area (outside and inside) and down left arm; Continues 3 months of burning sensation constantly.; swollen glands under arm that stings/burns.; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the arm left on 13Mar2021 at 11:45(at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none(it was reported as no health issues). The patient did not have any allergies to medications, food, or other products.Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via an unspecified route of administration in the left arm on 20Feb2021 at 11:45(at the age of 66-year-old) as a single dose for COVID-19 immunisation. On 16Mar2021 at 22:00 the patient experienced 3 days post vaccine, lime size lump under left arm and swollen glands under arm that stings/burns. Then lumps appeared in elbow area (outside and inside) and down left arm and continues 3 months of burning sensation constantly.  Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events 3 days post vaccine, lime size lump under left arm and swollen glands under arm that stings/burns. Then lumps appeared in elbow area (outside and inside) and down left arm and continues 3 months of burning sensation constantly were not resolved at the time of this report.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary mass, Burning sensation, Lymphadenopathy, Mass
Clinical narrative: 3 days post vaccine, lime size lump under left arm and swollen glands under arm that stings/burns.; Then lumps appeared in elbow area (outside and inside) and down left arm; Continues 3 months of burning sensation constantly.; swollen glands under arm that stings/burns.; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the arm left on 13Mar2021 at 11:45(at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none(it was reported as no health issues). The patient did not have any allergies to medications, food, or other products.Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via an unspecified route of administration in the left arm on 20Feb2021 at 11:45(at the age of 66-year-old) as a single dose for COVID-19 immunisation. On 16Mar2021 at 22:00 the patient experienced 3 days post vaccine, lime size lump under left arm and swollen glands under arm that stings/burns. Then lumps appeared in elbow area (outside and inside) and down left arm and continues 3 months of burning sensation constantly.  Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events 3 days post vaccine, lime size lump under left arm and swollen glands under arm that stings/burns. Then lumps appeared in elbow area (outside and inside) and down left arm and continues 3 months of burning sensation constantly were not resolved at the time of this report.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Cardiogenic shock, Faeces discoloured, Hypotension, Mental status changes
Clinical narrative: Diahrrea, vomiting, stomach pain, then emergency hospitalization. Heart failure, lung failure, kidney failure, and death within 6 days.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Multiple organ dysfunction syndrome, Pyrexia, Sepsis
Clinical narrative: Diahrrea, vomiting, stomach pain, then emergency hospitalization. Heart failure, lung failure, kidney failure, and death within 6 days.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Cardiac failure, Death, Diarrhoea, Endoscopy
Clinical narrative: Diahrrea, vomiting, stomach pain, then emergency hospitalization. Heart failure, lung failure, kidney failure, and death within 6 days.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lung neoplasm malignant, Renal failure, Vomiting
Clinical narrative: Diahrrea, vomiting, stomach pain, then emergency hospitalization. Heart failure, lung failure, kidney failure, and death within 6 days.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Pneumonia, Sepsis, Toxic shock syndrome
Clinical narrative: developed myocarditis along with septic shock, blood cultures positive for staph aureus. hospitalized from 3/4-3/18. started developing symptoms 6 days after second dose of covid vaccine.  3/5 ECHO Interpretation Summary  Normal left ventricular chamber size, wall thickness and moderately reduced systolic function. LVEF 37%. Global hypokinesis.  Normal diastolic function.  Normal right ventricular chamber size and systolic function. Normal pulmonary and elevated right atrial pressures.  Valves: mild mitral regurgitation, mild tricuspid regurgitation, mild pulmonic regurgitation  No pericardial effusion.  Normal ascending aorta.    6/10 ECHO Left Ventricle  The left ventricular systolic function is low normal. Quantified left ventricle ejection fraction is 52.9 %. The left ventricle is normal size. There is normal  left ventricular wall thickness. Wall motion is normal
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood culture positive, Echocardiogram abnormal, Ejection fraction decreased, Left ventricular dysfunction, Magnetic resonance imaging abnormal
Clinical narrative: developed myocarditis along with septic shock, blood cultures positive for staph aureus. hospitalized from 3/4-3/18. started developing symptoms 6 days after second dose of covid vaccine.  3/5 ECHO Interpretation Summary  Normal left ventricular chamber size, wall thickness and moderately reduced systolic function. LVEF 37%. Global hypokinesis.  Normal diastolic function.  Normal right ventricular chamber size and systolic function. Normal pulmonary and elevated right atrial pressures.  Valves: mild mitral regurgitation, mild tricuspid regurgitation, mild pulmonic regurgitation  No pericardial effusion.  Normal ascending aorta.    6/10 ECHO Left Ventricle  The left ventricular systolic function is low normal. Quantified left ventricle ejection fraction is 52.9 %. The left ventricle is normal size. There is normal  left ventricular wall thickness. Wall motion is normal
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging heart, Mitral valve incompetence, Myocarditis, Pericardial effusion, Pericarditis
Clinical narrative: developed myocarditis along with septic shock, blood cultures positive for staph aureus. hospitalized from 3/4-3/18. started developing symptoms 6 days after second dose of covid vaccine.  3/5 ECHO Interpretation Summary  Normal left ventricular chamber size, wall thickness and moderately reduced systolic function. LVEF 37%. Global hypokinesis.  Normal diastolic function.  Normal right ventricular chamber size and systolic function. Normal pulmonary and elevated right atrial pressures.  Valves: mild mitral regurgitation, mild tricuspid regurgitation, mild pulmonic regurgitation  No pericardial effusion.  Normal ascending aorta.    6/10 ECHO Left Ventricle  The left ventricular systolic function is low normal. Quantified left ventricle ejection fraction is 52.9 %. The left ventricle is normal size. There is normal  left ventricular wall thickness. Wall motion is normal
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary valve incompetence, Septic shock, Staphylococcal infection, Tricuspid valve incompetence, Ventricular hypokinesia
Clinical narrative: developed myocarditis along with septic shock, blood cultures positive for staph aureus. hospitalized from 3/4-3/18. started developing symptoms 6 days after second dose of covid vaccine.  3/5 ECHO Interpretation Summary  Normal left ventricular chamber size, wall thickness and moderately reduced systolic function. LVEF 37%. Global hypokinesis.  Normal diastolic function.  Normal right ventricular chamber size and systolic function. Normal pulmonary and elevated right atrial pressures.  Valves: mild mitral regurgitation, mild tricuspid regurgitation, mild pulmonic regurgitation  No pericardial effusion.  Normal ascending aorta.    6/10 ECHO Left Ventricle  The left ventricular systolic function is low normal. Quantified left ventricle ejection fraction is 52.9 %. The left ventricle is normal size. There is normal  left ventricular wall thickness. Wall motion is normal
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Vaccination site pain
Clinical narrative: feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain; This is a spontaneous report from a contactable consumer or other non-hcp (patient himself). A 61-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration in Arm Left on an unspecified date as dose 1, single and via an unspecified route of administration in Arm Left on an unspecified date (Lot number and Expiry date was not reported) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain on an unspecified date. This had been going on 2 maybe 3 months now. When the pain happens, it does not last long but was noticeable. He states he has a Dr appointment in Sep or Oct and he will call back again right before that to see if there was any updated information about this adverse event lasting this long and then he might ask the Dr to do testing on it. He will also start keeping a log about when this happens. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Pain in extremity
Clinical narrative: feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain; This is a spontaneous report from a contactable consumer or other non-hcp (patient himself). A 61-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration in Arm Left on an unspecified date as dose 1, single and via an unspecified route of administration in Arm Left on an unspecified date (Lot number and Expiry date was not reported) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain on an unspecified date. This had been going on 2 maybe 3 months now. When the pain happens, it does not last long but was noticeable. He states he has a Dr appointment in Sep or Oct and he will call back again right before that to see if there was any updated information about this adverse event lasting this long and then he might ask the Dr to do testing on it. He will also start keeping a log about when this happens. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain; This is a spontaneous report from a contactable consumer or other non-hcp (patient himself). A 61-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration in Arm Left on an unspecified date as dose 1, single and via an unspecified route of administration in Arm Left on an unspecified date (Lot number and Expiry date was not reported) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain on an unspecified date. This had been going on 2 maybe 3 months now. When the pain happens, it does not last long but was noticeable. He states he has a Dr appointment in Sep or Oct and he will call back again right before that to see if there was any updated information about this adverse event lasting this long and then he might ask the Dr to do testing on it. He will also start keeping a log about when this happens. The outcome of the event was unknown.  Information about lot/batch number has been requested.